Agilent Technologies (A) Stock Forecast & Price Target

$147.58 +1.71 (+1.17%)

Closing price 10/23/2025 03:59 PM Eastern

Extended Trading

$146.58 -1.00 (-0.67%)

As of 10/23/2025 07:30 PM Eastern

Compare

Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
0

Hold
6

Buy
9

Based on 15 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 6 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for A.

Consensus Price Target

$149.62
1.38% Upside

According to the 15 analysts' twelve-month price targets for Agilent Technologies, the average price target is $149.62. The highest price target for A is $170.00, while the lowest price target for A is $116.00. The average price target represents a forecasted upside of 1.38% from the current price of $147.58.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for A and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

A Analyst Ratings Over Time

Type	Current Forecast 10/24/24 to 10/24/25	1 Month Ago 9/24/24 to 9/24/25	3 Months Ago 7/26/24 to 7/26/25	1 Year Ago 10/25/23 to 10/24/24
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	6 Buy rating(s)	7 Buy rating(s)	8 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$149.62	$140.08	$139.77	$144.36
Forecasted Upside	1.38% Upside	12.70% Upside	16.31% Upside	10.43% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

A Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

A Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Agilent Technologies Stock vs. The Competition

Type	Agilent Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.33	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	1.38% Upside	1,305.04% Upside	12.12% Upside
News Sentiment Rating	Positive News See Recent A News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/14/2025	TD Cowen 4 of 5 stars	Dan Brennan Not Rated	Boost Target	Buy	$150.00 ➝ $162.00	+17.03%
10/9/2025	JPMorgan Chase & Co. 2 of 5 stars	Casey Woodring Not Rated	Boost Target	Overweight	$155.00 ➝ $165.00	+17.18%
10/8/2025	Rothschild Redb 0 of 5 stars		Upgrade	Strong-Buy
10/8/2025	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C)
10/8/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Leonard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$130.00 ➝ $170.00	+22.69%
10/8/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Natalya Davies Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$165.00	+19.08%
10/7/2025	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	In-Line	$128.00 ➝ $140.00	+0.72%
10/2/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$125.00 ➝ $150.00	+7.48%
9/15/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$140.00 ➝ $150.00	+21.76%
8/28/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catherine Schulte Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$141.00 ➝ $142.00	+15.54%
Get the Latest News and Ratings for A and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.
5/30/2025	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$135.00	+19.78%
4/21/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$135.00 ➝ $116.00	+16.44%
12/19/2024	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	P. Donnelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$165.00	+23.96%
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Neutral	$153.00 ➝ $150.00	+8.93%
11/26/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Market Perform	$140.00 ➝ $135.00	+1.41%
8/26/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$151.00	+7.19%
6/27/2024	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	D. Schenkel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
3/26/2024	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$67.00 ➝ $90.00	-38.30%
12/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$128.00 ➝ $145.00	+12.47%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:06 AM ET.

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 23, 2025. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

Agilent Technologies
Bull Case

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

The current stock price is around $145, reflecting a strong market position and investor confidence in the company's growth potential.
Agilent Technologies, Inc. reported a revenue increase of over 10% year-over-year, indicating robust demand for its products and services in the medical research sector.
The company has a solid return on equity of 25.51%, showcasing its efficiency in generating profits from shareholders' equity.
With a market capitalization of approximately $41.33 billion, Agilent Technologies, Inc. is well-positioned for stability and growth in the competitive market.
The firm has set ambitious earnings guidance for FY 2025, projecting earnings per share between 5.560 and 5.590, which could signal future profitability and investor returns.

Agilent Technologies
Bear Case

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

The company has a relatively high price-to-earnings (P/E) ratio of 34.22, which may suggest that the stock is overvalued compared to its earnings, potentially limiting future price appreciation.
Despite recent revenue growth, the competitive landscape in the medical research industry could pose challenges, as new entrants may impact market share and pricing power.
Agilent Technologies, Inc. has a beta of 1.26, indicating that its stock price is more volatile than the market, which could lead to higher risk for investors.
The company's debt-to-equity ratio of 0.53, while manageable, suggests that it relies on debt financing, which could be a concern if interest rates rise or if cash flow becomes constrained.
Recent institutional selling, such as the 10.2% reduction in holdings by Mutual of America Capital Management LLC, may indicate a lack of confidence among some investors regarding the company's short-term prospects.

A Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $149.62, with a high forecast of $170.00 and a low forecast of $116.00.
: 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 6 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" A shares.
: According to analysts, Agilent Technologies's stock has a predicted upside of 1.38% based on their 12-month stock forecasts.
: Over the previous 90 days, Agilent Technologies's stock had 2 upgrades by analysts.
: Agilent Technologies has been rated by research analysts at Barclays, Evercore ISI, JPMorgan Chase & Co., Robert W. Baird, Rothschild & Co Redburn, Rothschild Redb, TD Cowen, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.
: Analysts like Agilent Technologies more than other "medical" companies. The consensus rating for Agilent Technologies is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how A compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:A) was last updated on 10/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilent Technologies (A) Stock Forecast & Price Target